BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  CytoDyn to Present at the AACR Annual Meeting 2026

  April 14, 2026

   · 

  3 min read
• Press Releases

  IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout

  April 14, 2026

   · 

  3 min read
• Press Releases

  Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR

  April 14, 2026

   · 

  16 min read
• 

  Mergers & acquisitions

  Lilly wants to bridge cancer care gap with $300M ADC biotech buy

  Eli Lilly is putting its obesity windfall to work again, striking a new deal to acquire CrossBridge Bio, a small Texas biotech known for its cancer tech.

  April 14, 2026

   · 

  1 min read

   · 

  Gabrielle Masson
• Press Releases

  Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

  April 14, 2026

   · 

  3 min read
• Press Releases

  Neomorph to Highlight Progress in Targeted Protein Degradation Science at the American Association for Cancer Research Annual Meeting

  April 14, 2026

   · 

  3 min read
• Press Releases

  Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model

  April 14, 2026

   · 

  5 min read
• Press Releases

  Culture Biosciences Announces Strategic Addition to Its Board of Directors to Accelerate Hardware Commercialization and SaaS Growth

  April 14, 2026

   · 

  2 min read
• Press Releases

  Apotex Announces FDA Approval of First Generic Infuvite® Adult Injection (Single Dose Vial and Pharmacy Bulk package) with 180‑Day CGT Exclusivity for the Pharmacy bulk package in Partnership with Orbicular and Gland Pharma

  April 14, 2026

   · 

  4 min read
• Press Releases

  Phrontline Biopharma Presents Preclinical Data for TJ106, a Biparatopic HER2 Dual-Payload ADC, at American Association for Cancer Research Annual Meeting 2026

  April 14, 2026

   · 

  3 min read